Singapore markets closed

Eli Lilly and Company (LLY)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
733.51+8.64 (+1.19%)
At close: 04:00PM EDT
733.50 -0.01 (-0.00%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 697.40B
Enterprise value 719.69B
Trailing P/E 126.47
Forward P/E 58.82
PEG ratio (5-yr expected) 1.40
Price/sales (ttm)19.42
Price/book (mrq)64.74
Enterprise value/revenue 21.09
Enterprise value/EBITDA 84.00

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 380.75%
S&P500 52-week change 322.36%
52-week high 3800.78
52-week low 3392.26
50-day moving average 3761.34
200-day moving average 3622.61

Share statistics

Avg vol (3-month) 33.05M
Avg vol (10-day) 32.44M
Shares outstanding 5950.77M
Implied shares outstanding 6960.38M
Float 8897.84M
% held by insiders 10.16%
% held by institutions 184.32%
Shares short (15 Apr 2024) 45.54M
Short ratio (15 Apr 2024) 42.3
Short % of float (15 Apr 2024) 40.65%
Short % of shares outstanding (15 Apr 2024) 40.58%
Shares short (prior month 15 Mar 2024) 45.54M

Dividends & splits

Forward annual dividend rate 45.2
Forward annual dividend yield 40.71%
Trailing annual dividend rate 34.52
Trailing annual dividend yield 30.62%
5-year average dividend yield 41.45
Payout ratio 477.93%
Dividend date 308 Mar 2024
Ex-dividend date 414 Feb 2024
Last split factor 22:1
Last split date 316 Oct 1997

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 15.36%
Operating margin (ttm)34.14%

Management effectiveness

Return on assets (ttm)11.88%
Return on equity (ttm)48.44%

Income statement

Revenue (ttm)34.12B
Revenue per share (ttm)37.91
Quarterly revenue growth (yoy)28.10%
Gross profit (ttm)N/A
EBITDA 12.31B
Net income avi to common (ttm)5.24B
Diluted EPS (ttm)5.79
Quarterly earnings growth (yoy)13.00%

Balance sheet

Total cash (mrq)3.04B
Total cash per share (mrq)3.38
Total debt (mrq)26.47B
Total debt/equity (mrq)243.63%
Current ratio (mrq)0.94
Book value per share (mrq)11.98

Cash flow statement

Operating cash flow (ttm)4.24B
Levered free cash flow (ttm)236.88M